Journal of Leukemia
Open Access

Department of Urology, Dokkyo Medical University Saitama Medical Center, 2-1-50 Minamikoshigaya, Koshigaya, Saitama 353-8555, Japan

Publications

• Case Report   
  Is Kidney Transplantation a Relative Indication for Patients with Chronic Myeloid Leukemia (CML) in Sustained Remission with Imatinib?
  Author(s): Tadahiko Tokumoto*, Kiyoshi Setoguchi and Kazutaka Saito
  
  Currently, kidney transplantation is absolutely contraindicated for patients with Chronic Renal Failure (CRF) with active malignancy. However, there is controversy as to whether kidney transplantation can be safely performed in patients with a history of Chronic Myeloid Leukemia (CML) in remission. In this report, a 64-year-old male patient was diagnosed with CML approximately 17 years ago, achieved cytogenetic and molecular remission promptly after starting Imatinib, and remained in remission for more than 15 years with Imatinib therapy. However, Chronic Kidney Disease (CKD) due to DMN gradually worsened, and the patient underwent preemptive living donor kidney transplantation in July 2020. Imatinib for CML was discontinued because the patient maintained Deep Molecular Remission (DMR) of Major Molecular Response (MMR) for more than 15 years prior to kidney transplantation. After the .. View More»
  DOI: 10.35248/2329-6917.23.11.341

  Abstract HTML PDF